NEW YORK, September 22, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: HCP Inc. (NYSE: HCP), Medical Properties Trust
Inc. (NYSE: MPW), Ventas Inc. (NYSE: VTR), Health Care REIT Inc.
(NYSE: HCN), and Omega Healthcare Investors Inc. (NYSE: OHI). Free
research report on HCP Inc. can be accessed at
https://www.erionline.net/HCP.pdf On Monday,
September 21, 2015, the NASDAQ Composite ended at 4,828.96,
up 0.04%, the Dow Jones Industrial Average advanced 0.77%, to
finish the day at 16,510.19, and the S&P 500 closed at
1,966.97, up 0.46%. The gains were broad based as seven out of nine
sectors ended the session in positive. Register for your
complimentary reports at the links given below.
On Monday, shares in HCP Inc. recorded a trading volume of 3.35
million shares, lower than their three months average volume of
3.56 million shares. The stock ended the day 0.13% higher at
$38.65. Shares of the company traded
at a PE ratio of 48.31. Although, HCP Inc.'s stock has advanced
4.40% in the previous three months, it has lost 4.59% in the last
one month and 8.47% on YTD basis. The company is trading above its
50-day moving average by 2.19%. Furthermore, shares of HCP Inc.
have a Relative Strength Index (RSI) of 59.84. Sign up and read the
free notes on HCP at:
https://www.erionline.net/HCP.pdf
Medical Properties Trust Inc.'s stock gained 1.86%, to close
Monday's session at $11.49. The stock
recorded a trading volume of 1.95 million shares, below its three
months average volume of 3.20 million shares. Over the last one
month and the previous three months, Medical Properties Trust
Inc.'s shares have declined 8.00% and 13.37%, respectively.
Additionally, the stock has lost 12.18% since the start of this
year. The company is trading 6.00% and 13.69% below its 50-day and
200-day moving averages, respectively. Furthermore, Medical
Properties Trust Inc.'s stock traded at a PE ratio of 21.68 and has
an RSI of 48.93. The complimentary notes on MPW can be downloaded
in PDF format at:
https://www.erionline.net/MPW.pdf
Ventas Inc.'s stock finished Monday's session 1.10% higher at
$56.77. A total of 2.11 million
shares were traded, which was below its three months average volume
of 2.81 million shares. Over the last one month and the previous
three months, Ventas Inc.'s shares have declined 4.93% and 10.33%,
respectively. Additionally, the stock has lost 17.89% since the
beginning of 2015. The company's shares are trading below their
50-day and 200-day moving averages by 6.09% and 15.65%,
respectively. Ventas Inc.'s stock traded at a PE ratio of 38.10 and
has an RSI of 52.77. Register for free on Equity Research Institute
and access the latest research on VTR at:
https://www.erionline.net/VTR.pdf
On Monday, shares in Health Care REIT Inc. ended the session
0.55% higher at $67.73. The stock
reported a trading volume of 2.25 million shares, below its three
months average volume of 2.39 million shares. Shares of the company
traded at a PE ratio of 51.31. Although, Health Care REIT Inc.'s
shares have advanced 1.49% in the previous three months, it has
declined 2.36% in the last one month and 7.41% on YTD basis. The
company is trading 2.21% above its 50-day moving average. Moreover,
shares of Health Care REIT Inc. have an RSI of 62.94. The complete
research on HCN is available for free at:
https://www.erionline.net/HCN.pdf
Omega Healthcare Investors Inc.'s stock advanced 1.99%, to close
the day at $35.44. The stock recorded
a trading volume of 1.27 million shares, below its three months
average volume of 1.58 million shares. Over the last one month and
since the start of this year, Omega Healthcare Investors Inc.'s
shares have fallen by 3.51% and 5.51%, respectively. However, the
stock has advanced 0.48% in the previous three months. The
company's shares are trading 1.51% above their 50-day moving
average. Additionally, Omega Healthcare Investors Inc. traded at a
PE ratio of 24.27 and has an RSI of 62.97. Free in-depth research
on OHI is available at:
https://www.erionline.net/OHI.pdf
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the Sponsor (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.erionline.net.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.erionline.net